BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Padrones S, Garcia-Vidal C, Fernández-Serrano S, Fernández A, Masuet C, Carratalà J, Coromines M, Ardanuy C, Gudiol F, Manresa F, Dorca J. Impact of antibiotic therapy on systemic cytokine expression in pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis 2010;29:1243-51. [PMID: 20567869 DOI: 10.1007/s10096-010-0993-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Calbo E, Garau J. Factors affecting the development of systemic inflammatory response syndrome in pneumococcal infections: . Current Opinion in Infectious Diseases 2011;24:241-7. [DOI: 10.1097/qco.0b013e3283463e45] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Feldman C, Anderson R. Bacteraemic Pneumococcal Pneumonia: Current Therapeutic Options. Drugs 2011;71:131-53. [DOI: 10.2165/11585310-000000000-00000] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
3 Menéndez R, Sahuquillo-Arce JM, Reyes S, Martínez R, Polverino E, Cillóniz C, Córdoba JG, Montull B, Torres A. Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia. Chest 2012;141:1537-45. [PMID: 22194589 DOI: 10.1378/chest.11-1446] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 6.3] [Reference Citation Analysis]
4 Brunaugh AD, Sharma S, Smyth H. Inhaled fixed-dose combination powders for the treatment of respiratory infections. Expert Opin Drug Deliv 2021;18:1101-15. [PMID: 33632051 DOI: 10.1080/17425247.2021.1886074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Haran JP, Buglione-corbett R, Lu S. Cytokine markers as predictors of type of respiratory infection in patients during the influenza season. The American Journal of Emergency Medicine 2013;31:816-21. [DOI: 10.1016/j.ajem.2013.01.030] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
6 Saballs M, Parra S, Sahun P, Pellejà J, Feliu M, Vasco C, Gumà J, Borràs JL, Masana L, Castro A. HDL-c levels predict the presence of pleural effusion and the clinical outcome of community-acquired pneumonia. Springerplus 2016;5:1491. [PMID: 27652064 DOI: 10.1186/s40064-016-3145-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
7 Broers CJ, Gemke RJ, Morré SA, Weijerman ME, van Furth AM. Increased production of interleukin-10 in children with Down syndrome upon ex vivo stimulation with Streptococcus pneumoniae. Pediatr Res 2014;75:109-13. [DOI: 10.1038/pr.2013.173] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
8 Fernández-Serrano S, Dorca J, Garcia-Vidal C, Fernández-Sabé N, Carratalà J, Fernández-Agüera A, Corominas M, Padrones S, Gudiol F, Manresa F. Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial. Crit Care 2011;15:R96. [PMID: 21406101 DOI: 10.1186/cc10103] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 6.8] [Reference Citation Analysis]
9 Nascimento-Carvalho EC, Vasconcellos ÂG, Clarêncio J, Andrade D, Barral A, Barral-Netto M, Nascimento-Carvalho CM. Evolution of cytokines/chemokines in cases with community-acquired pneumonia and distinct etiologies. Pediatr Pulmonol 2020;55:169-76. [PMID: 31553527 DOI: 10.1002/ppul.24533] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Waterer G, Rello J. Why should we measure bacterial load when treating community-acquired pneumonia? Curr Opin Infect Dis 2011;24:137-41. [PMID: 21301334 DOI: 10.1097/QCO.0b013e328343b70d] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
11 Meijvis SCA, van de Garde EMW, Rijkers GT, Bos WJW. Treatment with anti-inflammatory drugs in community-acquired pneumonia: Review: Anti-inflammatory drugs in CAP. Journal of Internal Medicine 2012;272:25-35. [DOI: 10.1111/j.1365-2796.2012.02554.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]